Eiken Chemical Transfers Manufacturing and Marketing Rights of Two Contrast Agents to Guerbet Japan.Tokyo, Japan, Oct 17, 2005 - (JCNN JCNN Japan Corporate News Network ) - Eiken Chemical announced on October 17 that it has transferred the manufacturing and marketing rights to its two contrast agents, Hexabrix 320 for urography urography /urog·ra·phy/ (u-rog´rah-fe) radiography of any part of the urinary tract. ascending urography , cystoscopic urography retrograde u. and angiography and Magnescope Syringe for MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. , to Guerbet Japan, a Japanese subsidiary of French contrast agent manufacturer Guerbet AG. With this move, Eiken Chemical aims to concentrate its management resources on the clinical diagnostic business while Guerbet will seek to increase its presence in Japan. In line with Eiken Chemical's announcement, Tanabe Seiyaku, the current distributor of Hexabrix 320 and Magnescoep, announced on the same day that it has reached an agreement with Terumo, whereby it will transfer the sales of the two products to Terumo as of January 1, 2006. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion